НовостиBenzingaZenas BioPharma Presents New Obexelimab Data In Immunoglobulin G4-Related Disease At 6th International Symposium On IgG4-Related Disease Zenas BioPharma Presents New Obexelimab Data In Immunoglobulin G4-Related Disease At 6th International Symposium On IgG4-Related Disease Benzinga 2026.10.12 11:07 (GMT+0) Открыть на Benzinga Другие новости